Skip to main content
Premium Trial:

Request an Annual Quote

Jenne Britell, Jeffrey Leiden

Jenne Britell and Jeffrey Leiden have told Quest Diagnostics that they will not seek reelection to the company's board at its annual shareholders' meeting to be held on May 14, Quest said in a document filed with the US Securities and Exchange Commission. They informed the company on Feb. 18. Quest previously announced that Denise Morrison had been elected to the board, increasing its size to 11 directors from 10.